483
Hetero Drugs Ltd. - Unit 1Hetero Drugs Ltd. - Unit 1 – FDA 483, May 16, 2025
Record Details
Hetero Drugs Ltd. - Unit 1, an API manufacturer in Gummadidala, Telangana, India, was cited with two observations during an FDA inspection. The firm failed to conduct adequate risk assessments and testing for the formation of a known carcinogen in drug products and lacked proper cleaning validation procedures to prevent hazardous drug residue cross-contamination on shared equipment. These issues indicate significant concerns regarding product quality and safety.
View Company Profile
ID · 380fe241-c7a9-4330-bbe5-26066c4980b8
Other documents for Hetero Drugs Ltd. - Unit 1
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.